MPs concern of pharma companies disclosure of payments 2016 Kingdom

This statistic presents the extent to which healthcare professionals are able to prevent publication of monetary transactions with pharmaceutical companies and whether this compromises the value of the payment disclosure initiative, in the United Kingdom (UK) in 2016, by political party. Over half of Labour MPs (57 percent) thought it would compromise the value of the payment disclosure initiative a lot, compared to just under a quarter of Conservative MPs.

To what extent does the ability of healthcare professionals to prevent publication of monetary transactions with pharmaceutical companies compromise the payment disclosure initiative?

Characteristic	A lot	A little	Not at all
Conservative MPs	24%	59%	17%
Labour MPs	57%	29%	14%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

April 2016

More information

Region

United Kingdom

Survey time period

2016

Number of respondents

122*

Supplementary notes

Exact formulation of the question: "To what extent does the ability of healthcare professionals to prevent publication of the details of transactions between themselves and pharmaceutical companies, under the Data Protection Act, compromises the value of the payment disclosure initiative?"

* n (Conservative MPs)= 57; n (Labour MPs)=49.

Citation formats